Back to Results

Sona Nanotech Inc (SNANF)

Featured in Overvalued Stocks

Sona Nanotech Inc. is a common stock listing on OTC Markets tied to a healthcare company focused on nanotechnology and life sciences. The company develops gold nanoparticle-based technologies in the United States and Canada for potential use in therapy and diagnostics. Its research work includes applications such as photothermal therapy, tumor targeting, antibacterial uses, and drug delivery, along with diagnostic tools for imaging, immunoassay, and biosensing. Sona Nanotech also works on targeted hyperthermia therapy for cancer tumors and on diagnostic products such as lateral flow assay rapid tests and bovine tuberculosis tests. Founded in 2013, the company is based in Halifax, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-SNAN.F
$0.16
-30.3% Downside
Overvalued
—
—
—
Fair
—
—
—
0.0%
September 24, 2026
-14.6x
-56.1x
—
25.624 M
29.673 M
0.9%
84.5%
-1,332.9
—
46.0%
Valuation • Fair Value

Sona Nanotech Inc (OTC-SNAN.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Sona Nanotech Inc (OTC-SNAN.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.16

Estimated downside of 30.3% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.16

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Sona Nanotech Inc (OTC-SNAN.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Sona Nanotech Inc (OTC-SNAN.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

-1.562 M

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Sona Nanotech Inc (OTC-SNAN.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Sona Nanotech Inc (OTC-SNAN.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

-1,332.9

Lower score that deserves closer risk review.

FCF / Net Income

46.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Sona Nanotech Inc (OTC-SNAN.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Sona Nanotech Inc (OTC-SNAN.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 24, 2026

Days to Earnings

65

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Sona Nanotech Inc (OTC-SNAN.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Sona Nanotech Inc (OTC-SNAN.F) Stock Forecast & Technical Outlook

Review Sona Nanotech Inc (OTC-SNAN.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Sona Nanotech Inc (OTC-SNAN.F) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Sona Nanotech Inc (OTC-SNAN.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Sona Nanotech Inc (OTC-SNAN.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Sona Nanotech Inc (OTC-SNAN.F) Stock FAQ

Quick answers about Sona Nanotech Inc (OTC-SNAN.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.16
Estimated downside 30.3%
Valuation Rating
Overvalued
Estimated downside of 30.3%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Sona Nanotech Inc (OTC-SNAN.F) is $0.16. This implies an estimated downside of 30.3% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 30.3% versus the current market price.

An analyst price target for Sona Nanotech Inc (OTC-SNAN.F) is not currently available in the latest data file.

The current financial health read for Sona Nanotech Inc (OTC-SNAN.F) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Sona Nanotech Inc (OTC-SNAN.F) is September 24, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Sona Nanotech Inc (OTC-SNAN.F) is -14.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Sona Nanotech Inc is 25.624 M.

The current enterprise value listed for Sona Nanotech Inc is 29.673 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Sona Nanotech Inc is OTC-SNAN.F, and the stock is listed on OTC Markets.

Sona Nanotech Inc (OTC-SNAN.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Sona Nanotech Inc is 0.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Sona Nanotech Inc is 84.5%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on OTC Markets View more

Lonza Group AG (LZAGY) Lonza Group AG (LZAGY)
WuXi Biologics (WXIBF) WuXi Biologics (WXIBF)
RADNOSTIX, INC (INIS) RADNOSTIX, INC (INIS)
Malin Corporation plc (MLLNF) Malin Corporation plc (MLLNF)
Bioqual Inc (BIOQ) Bioqual Inc (BIOQ)
Pharma-Bio Serv Inc (PBSV) Pharma-Bio Serv Inc (PBSV)
Reflect Scientific Inc (RSCF) Reflect Scientific Inc (RSCF)
Cannabis Bioscience International Holdings Inc (CBIH) Cannabis Bioscience International Holdings Inc (CBIH)
BNB Plus Corp (BNBX) BNB Plus Corp (BNBX)
Pressure Biosciences Inc (PBIO) Pressure Biosciences Inc (PBIO)
EVIO Inc (EVIO) EVIO Inc (EVIO)
MetaStat Inc (MTST) MetaStat Inc (MTST)
Telesis Bio Inc (TBIO) Telesis Bio Inc (TBIO)
BG Medicine Inc (BGMD) BG Medicine Inc (BGMD)
Arrayit Corporation (ARYC) Arrayit Corporation (ARYC)
Response Genetics Inc (RGDXQ) Response Genetics Inc (RGDXQ)